1. Home
  2. CCEL vs BHM Comparison

CCEL vs BHM Comparison

Compare CCEL & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$4.39

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

N/A

Current Price

$8.51

Market Cap

35.7M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
BHM
Founded
1989
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
35.7M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
CCEL
BHM
Price
$4.39
$8.51
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
21.3K
3.9K
Earning Date
04-14-2026
01-01-0001
Dividend Yield
4.26%
4.54%
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$25,384,279.00
$68,734,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$65.14
N/A
Revenue Growth
9.76
36.88
52 Week Low
$2.72
$8.05
52 Week High
$5.01
$13.59

Technical Indicators

Market Signals
Indicator
CCEL
BHM
Relative Strength Index (RSI) 63.79 44.63
Support Level $3.10 $8.11
Resistance Level $4.41 $9.55
Average True Range (ATR) 0.38 0.27
MACD 0.08 0.05
Stochastic Oscillator 65.90 39.25

Price Performance

Historical Comparison
CCEL
BHM

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

Share on Social Networks: